Drug-associated bone resorption with potential dental and implant implications.

Romanos, Georgios E; Vaglica, Michael; Sculean, Anton (2022). Drug-associated bone resorption with potential dental and implant implications. Periodontology 2000, 90(1), pp. 236-246. Wiley 10.1111/prd.12461

Text Periodontology_2000_-_2022_-_Romanos_-_Drug_associated_bone_resorption_with_potential_dental_and_implant_implications.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy

Every year more and more innovative pharmacological agents are introduced medicine, to treat systemic diseases. Due to these rapid and recent advancements, many patients are receiving treatment with a high variety of drugs, such as selective serotonin reuptake inhibitors, bisphosphonates, tumor necrosis factor (TNF)-α inhibitors, cyclosporine, and steroids. Since implant and osseous surgery are common treatment modalities used, within dentistry, it is of critical important to acknowledge and discuss the potential effects of selective serotonin reuptake inhibitors, bisphosphonates, TNF-α inhibitors, cyclosporine, and steroids, on bone healing. The present paper discusses the possible detrimental ramifications and risks these drug classes may have on bone healing.

Interest & Impact

Downloads

1 since deposited on 02 Dec 2022
1 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item